These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16508724)

  • 61. Letter to the editor in response to "Stage 1, grade 3 endometrioid adenocarcinoma of the endometrium: An analysis of clinical outcomes and patterns of recurrence".
    Pollock J
    Gynecol Oncol; 2010 Jun; 117(3):507; author reply 507-8. PubMed ID: 20189231
    [No Abstract]   [Full Text] [Related]  

  • 62. Objective risk definition for endometrial lesion spectrum: a diagnostic algorithm.
    Yilmaz I; Baloglu H; Haholu A; Berber U; Yildirim S; Ergur AR
    Gynecol Oncol; 2007 May; 105(2):451-6. PubMed ID: 17303223
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors.
    Ritterhouse LL; Howitt BE
    Surg Pathol Clin; 2016 Sep; 9(3):405-26. PubMed ID: 27523969
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
    An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
    Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF; Kurman RJ
    Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors.
    Huvila J; Brandt A; Rojas CR; Pasanen S; Talve L; Hirsimäki P; Fey V; Kytömäki L; Saukko P; Carpén O; Soini JT; Grénman S; Auranen A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1226-31. PubMed ID: 19823059
    [TBL] [Abstract][Full Text] [Related]  

  • 67. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.
    DeRycke MS; Andersen JD; Harrington KM; Pambuccian SE; Kalloger SE; Boylan KL; Argenta PA; Skubitz AP
    Am J Clin Pathol; 2009 Dec; 132(6):846-56. PubMed ID: 19926575
    [TBL] [Abstract][Full Text] [Related]  

  • 68. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
    Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Microsatellite instability analysis in uterine cavity washings as a screening tool for endometrial cancer in Lynch syndrome.
    Bouquier J; Blons H; Narjoz C; Lécuru F; Laurent-Puig P; Bats AS
    Fam Cancer; 2011 Dec; 10(4):655-7. PubMed ID: 21822721
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MicroRNA-21 expression in cancer cells is an independent biomarker of progression-free survival of endometrioid endometrial carcinoma.
    Sato K; Miyamoto M; Takano M; Tsuda H
    Virchows Arch; 2021 Nov; 479(5):883-891. PubMed ID: 34331128
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Endometrial adenocarcinoma: a primer for the generalist.
    Hernandez E
    Obstet Gynecol Clin North Am; 2001 Dec; 28(4):743-57. PubMed ID: 11766149
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Estimated intermediate risk endometrial cancer: debate and new perspectives on therapy individualization and prognosis establishment starting from a peculiar case.
    Gizzo S; Fabris A; Litta P; Saccardi C
    Int J Clin Exp Pathol; 2014; 7(5):2664-9. PubMed ID: 24966983
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunohistochemical expression of core 2 β1,6-N-acetylglucosaminyl transferase 1 (C2GnT1) in endometrioid-type endometrial carcinoma: a novel potential prognostic factor.
    Miyamoto T; Suzuki A; Asaka R; Ishikawa K; Yamada Y; Kobara H; Nakayama J; Shiozawa T
    Histopathology; 2013 Jun; 62(7):986-93. PubMed ID: 23617619
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.
    Clarke BA; Gilks CB
    J Clin Pathol; 2010 May; 63(5):410-5. PubMed ID: 20418232
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
    Stasenko M; Tunnage I; Ashley CW; Rubinstein MM; Latham AJ; Da Cruz Paula A; Mueller JJ; Leitao MM; Friedman CF; Makker V; Soslow RA; DeLair DF; Hyman DM; Zamarin D; Alektiar KM; Aghajanian CA; Abu-Rustum NR; Weigelt B; Cadoo KA
    Gynecol Oncol; 2020 Jan; 156(1):194-202. PubMed ID: 31757464
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma.
    Brett MA; Atenafu EG; Singh N; Ghatage P; Clarke BA; Nelson GS; Bernardini MQ; Köbel M
    Int J Gynecol Pathol; 2021 Mar; 40(2):116-123. PubMed ID: 32265358
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Incorporation of molecular characteristics into endometrial cancer management.
    Vermij L; Smit V; Nout R; Bosse T
    Histopathology; 2020 Jan; 76(1):52-63. PubMed ID: 31846532
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synchronous endometrioid adenocarcinomas in the uterine cervix and corpus.
    Obata T; Nakamura M; Mizumoto Y; Matsumoto T; Takakura M; Fujiwara H
    J Obstet Gynaecol Res; 2016 Oct; 42(10):1390-1394. PubMed ID: 27354119
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
    Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
    Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular and pathologic aspects of endometrial carcinogenesis.
    Hecht JL; Mutter GL
    J Clin Oncol; 2006 Oct; 24(29):4783-91. PubMed ID: 17028294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.